4 Ways Sullivan & Cromwell Can Talk Up Valeant's Salix Bid
Less than a year after losing a very public battle to buy drugmaker Allergan Inc. in which it played the role of hostile bidder, Valeant Pharmaceuticals International Inc. has found itself...To view the full article, register now.
Already a subscriber? Click here to view full article